Volume 12 - Issue 1 - January 2012

Evolution of Atrial Fibrillation Ablation at Sequoia Hospital

Example AF Case

The patient is a 29-year-old female student who was first diagnosed with atrial fibrillation (AF) in 2005. Her first episode was persistent, requiring cardioversion. She is physically active and runs on a regular basis. She continued to have paroxysmal AF with dizziness after running.



Making the Transition from the EP Lab to EP Industry: The PrepMD Experience

In this article, the author shares her experience as a recent student and graduate of the PrepMD training program.

PrepMD is a training program in Braintree, Massachusetts that prepares individuals for a career in the medical device industry. The focus of the program is Cardiac Rhythm Management (CRM) technology, with additional instruction in EP therapies, as well as business and sales training. 



Spotlight Interview: Holy Cross Hospital

Describe your city or general regional area. How does it differ from the rest of the U.S.?

Situated in sunny South Florida, Holy Cross Hospital serves a broad range of patients. Our patient volume has a distinct seasonal ebb and flow, with patients from the northeast corridor of the United States and Canada affectionately referred to as “snowbirds.”



Book Review: The Calling

The Calling, a collection of personal stories on the unique relationships between patients and their physicians, was written by Blair Grubb, MD and recently published by the University of Toledo Press. In this interview we talk with Dr. Grubb, Director of Electrophysiology Services at the University of Toledo Medical Center, about his published work.



Hypertrophic Cardiomyopathy and New Guidelines for Electrophysiologists

“Hard to treat and harder to diagnose” is how many clinicians have often thought of hypertrophic cardiomyopathy (HCM). As electrophysiologists, it hasn’t always been on the radar since it’s often viewed as a rare, somewhat obscure disease. However, according to Dr. Barry J. Maron, one of the world’s experts on HCM and an investigator at the Minneapolis Heart Institute, HCM is the most common cause of sudden death in young people.1 As such, new developments on HCM are critical for EPs to understand and integrate into their practice. This article outlines the newly published recommendations for treating HCM patients.



The Unseen Risks in the EP Lab: The Inconvenient Truth

In this article, Dr. Spear discusses the risks of radiation exposure, and shares strategies for reducing radiation exposure for the EP operator, staff, and patient.

It is 6 am and my alarm clock is ringing. I am waking up to start another day as an EP fellow in a very busy ablation lab. I arrive at the hospital to see the EP lab schedule; I am assigned to “A Lab”, which means I will be in the ablation lab all day. 



10-Minute Interview: James Reiss, MD

This month, Dr. James Reiss from PeaceHealth Southwest Heart and Vascular Clinic in Vancouver, Washington, was nominated by colleagues. Learn more about Dr. Reiss’ work here.



New Research in Long QT Syndrome: Interview with Dr. Michael Ackerman

In this interview EP Lab Digest speaks with Michael J. Ackerman, MD, PhD about his recent research on treadmill stress testing to unmask patients with concealed long QT syndrome (LQTS).1 Dr. Ackerman is the director of Mayo Clinic’s Long QT Syndrome Clinic and the Windland Smith Rice Sudden Death Genomics Laboratory in Rochester, Minnesota.

 



Applications in the EP Lab: The Odyssey Cinema Studio

In this article we speak with J. Brian DeVille, MD, FACC, FHRS, cardiac electrophysiologist at THE HEART HOSPITAL Baylor Plano, which is the first in the world to implement the new Stereotaxis Epoch platform for use in their EP and cath labs. On December 13, THE HEART HOSPITAL Baylor Plano became the first hospital in the world to perform an electrophysiology procedure using the new Epoch platform. THE HEART HOSPITAL Baylor Plano is located in Plano, Texas.



Stuck in the Middle: Afib Patients on Rate Control

Those with atrial fibrillation know the symptoms of a wildly beating heart, the fatigue and downright helplessness when trying to contend with the condition. Patients are desperate to relieve those symptoms and will follow recommendations, often without question. For some physicians, especially the primary care providers who aren’t as well versed in the details of afib treatments, it appears that rate control is the treatment of choice for everyone — regardless of whether or not they are symptomatic.



  • « Previous
  •  | Page 1 of 2 | 
  • Next »